Exact Sciences Corporation (EXAS:NASDAQ) closed at $104.91 on March 20, 2026, unchanged on the day. The stock trades 0.1% below its 52-week high of $104.98 and 170.3% above its 52-week low of $38.81. Exact Sciences Corporation is part of the Health Care sector (Biotechnology: Commercial Physical & Biological Resarch).
In 252 trading sessions since October 15, 2025, EXAS closed higher on 66 days (26%). Its best day was November 19, 2025 (+23.68%) and its worst was November 6, 2025 (-3.46%). The stock moved 10% or more in a single session 2 times. It opened at least 5% above the previous day's high 1 time.
Exact Sciences Corporation, a molecular diagnostics company, focuses on developing products for the early detection and prevention of various cancers in the United States. The company develops the Cologuard, a non-invasive stool-based DNA screening test for the early detection of colorectal cancer and pre-cancer. It has a collaboration, license, and purchase agreement with Genzyme Corporation; and license agreement with MAYO Foundation for Medical Education and Research. Exact Sciences Corporation was founded in 1995 and is headquartered in Madison, Wisconsin.
Find more stocks like EXAS with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.